Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 2:30 pm Purchase |
2022-12-31 | 13G | CinCor Pharma, Inc. CINC |
PERCEPTIVE ADVISORS LLC | 2,576,325 5.900% |
2,576,325 (New Position) |
Filing History |
| 2023-02-14 2:30 pm Purchase |
2022-09-16 | 13G | Larimar Therapeutics, Inc. LRMR |
PERCEPTIVE ADVISORS LLC | 2,860,000 6.600% |
2,860,000 (New Position) |
Filing History |
| 2023-02-03 4:31 pm Unchanged |
2023-02-01 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 3,501,265 17.900% |
0 (Unchanged) |
Filing History |
| 2023-02-02 5:01 pm Purchase |
2023-02-01 | 13D | Athenex, Inc. ATNX |
PERCEPTIVE ADVISORS LLC | 776,623 9.900% |
100,000 (+14.78%) |
Filing History |
| 2023-01-13 5:07 pm Unchanged |
2023-01-10 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,486,992 36.900% |
0 (Unchanged) |
Filing History |
| 2022-12-21 4:30 pm Purchase |
2022-12-19 | 13D | Astria Therapeutics, Inc. ATXS |
PERCEPTIVE ADVISORS LLC | 2,487,802 9.900% |
2,487,802 (New Position) |
Filing History |
| 2022-12-06 4:30 pm Purchase |
2022-12-02 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 3,501,265 17.900% |
2,603,762 (+290.11%) |
Filing History |
| 2022-11-18 4:31 pm Purchase |
2022-11-17 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV |
PERCEPTIVE ADVISORS LLC | 3,007,858 14.400% |
3,007,858 (New Position) |
Filing History |
| 2022-11-03 4:33 pm Sale |
2022-10-31 | 13G | Quotient Limited QTNT |
PERCEPTIVE ADVISORS LLC | 0 0.000% |
-405,020 (Position Closed) |
Filing History |
| 2022-09-23 4:31 pm Purchase |
2022-09-16 | 13G | Relmada Therapeutics, Inc. RLMD |
PERCEPTIVE ADVISORS LLC | 2,099,952 7.000% |
2,099,952 (New Position) |
Filing History |
| 2022-09-02 4:50 pm Purchase |
2022-09-02 | 13D | Solid Biosciences Inc. SLDB |
PERCEPTIVE ADVISORS LLC | 897,503 11.900% |
3,333 (+0.37%) |
Filing History |
| 2022-08-09 09:15 am Sale |
2022-08-09 | 13D | Landos Biopharma, Inc. LABP |
PERCEPTIVE ADVISORS LLC | 1,486,992 36.900% |
-309,092 (-17.21%) |
Filing History |
| 2022-07-18 8:59 pm Purchase |
2022-07-05 | 13G | Inhibrx Biosciences, Inc. INBX |
PERCEPTIVE ADVISORS LLC | 1,968,744 5.000% |
1,968,744 (New Position) |
Filing History |
| 2022-07-01 4:45 pm Purchase |
2022-06-30 | 13D | Athira Pharma, Inc. ATHA |
PERCEPTIVE ADVISORS LLC | 4,811,149 12.800% |
1,385,233 (+40.43%) |
Filing History |
| 2022-06-21 09:07 am Purchase |
2022-06-08 | 13G | Amylyx Pharmaceuticals, Inc. AMLX |
PERCEPTIVE ADVISORS LLC | 2,971,413 5.100% |
2,971,413 (New Position) |
Filing History |
| 2022-04-25 7:02 pm Unchanged |
2022-04-25 | 13D | Crinetics Pharmaceuticals, Inc. CRNX |
PERCEPTIVE ADVISORS LLC | 5,333,532 10.000% |
0 (Unchanged) |
Filing History |
| 2022-04-20 9:17 pm Purchase |
2022-04-18 | 13D | Crinetics Pharmaceuticals, Inc. CRNX |
PERCEPTIVE ADVISORS LLC | 5,333,532 10.000% |
1,674,151 (+45.75%) |
Filing History |
| 2022-04-14 5:10 pm Purchase |
2022-04-07 | 13D | Lyra Therapeutics, Inc. LYRA |
PERCEPTIVE ADVISORS LLC | 9,146,731 24.800% |
5,924,170 (+183.83%) |
Filing History |
| 2022-03-02 4:16 pm Sale |
2022-02-23 | 13G | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,356,043 9.700% |
-400 (-0.00%) |
Filing History |
| 2022-03-02 3:38 pm Purchase |
2022-02-23 | 13D | Amicus Therapeutics, Inc. FOLD |
PERCEPTIVE ADVISORS LLC | 27,356,443 9.700% |
797,000 (+3.00%) |
Filing History |